The WoePal GmbH is your partner for gas sensor technology . We provide expertise ranging from in-situ gas sensing systems , remote sensing and network technologies to data analytics, assessments and presentation of results. We have your back whether you are looking for a holistic solution or individual components to realize your application. You have an application in mind but are not able to shoulder the development alone? We provide information and partnership including finding funding opportunities on regional, national, and European level.

    

 - Customized Health via Air Monitoring Platform -

CHAMP is an innovation project that uniquely combines research and development of an integrated system with novel portable air quality sensors, continuous physiological monitoring and respiratory health expertise. It is an international cooperation project for research and development between the WoePal GmbH (Germany), NVISION Systems & Technologies S.L. (Catalonia, Spain) and medical end-users, and is funded by respective national agencies.

Humanity today faces a global problem that is significantly anthropogenic in origin: Air pollution. According to recent WHO and research estimates, air pollution is responsible for the deaths of more than 7 million people per year. Air pollution is responsible for exacerbating noncommunicable diseases such as chronic obstructive pulmonary disease (COPD), cardiovascular disease, cancer, and diabetes. Among respiratory diseases that can be exacerbated by air pollution, COPD and asthma have proven associations, while there are strong indications that it excarbates COVID-19 and associated pneumonia. CHAMP's approach focuses on two major sources of anthropogenic air pollution that have been shown to impact health and for which sensor integration enables accurate tracking at the personal level, nitrogen dioxide (NO2) and particulate matter (PM2.5).

The air quality measurement and personal health monitoring system, which is being developed through international collaboration between the WoePal GmbH and a number of Catalan actors. It consists of a portable air quality sensor system from WoePal GmbH and artificial intelligence-equipped data acquisition and processing modules suitable for personalized patient monitoring. In the development phase of the system, a clinical trial will be conducted with patients suffering from COVID-19 to monitor the feasibility of early detection of severe progression of respiratory tract diseases.


The work conducted by WoePal GmbH in the project is funded by the German Federal Ministry for Economic Affairs and Energy, in the frame of the Zentrales Innovationsprogramm Mittelstand (ZIM).